DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB06147
| null |
Sulfathiazole
|
72-14-0
|
Y7FKS2XWQH
|
2-(p-Aminobenzenesulfonamido)thiazole | 2-(p-Aminobenzenesulphonamido)thiazole | 2-(Sulfanilylamino)thiazole | 2-Sulfanilamidothiazol | 2-Sulfanilamidothiazole | 2-Sulfonamidothiazole | 4-Amino-N-2-thiazolylbenzenesulfonamide | N(1)-2-Thiazolylsulfanilamide | N1-2-Thiazolylsulfanilamide | Sulfanilamidothiazole | Sulfathiazol | Sulfathiazole | Sulfathiazolum | Sulfatiazol | Sulphathiazole
|
JNMRHUJNCSQMMB-UHFFFAOYSA-N
|
DB06148
| null |
Mianserin
|
24219-97-4
|
250PJI13LM
|
1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine | Mianserin | Mianserina | Mianserine | Miansérine | Mianserinum | Mianseryna
|
UEQUQVLFIPOEMF-UHFFFAOYSA-N
|
DB06149
| null |
Teicoplanin
|
61036-62-2
|
4U3D3YY81M
|
Teichomycin A2 | Teicoplanin | teicoplanina | téicoplanine | teicoplaninum
|
BJNLLBUOHPVGFT-CAYRISATSA-N
|
DB06150
| null |
Sulfadimethoxine
|
122-11-2
|
30CPC5LDEX
|
2,4-dimethoxy-6-sulfanilamido-1,3-diazine | 2,6-dimethoxy-4-(p-aminobenzenesulfonamido)pyrimidine | 2,6-dimethoxy-4-sulfanilamidopyrimidine | 4-amino-N-(2,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide | 6-sulfanilamido-2,4-dimethoxypyrimidine | N(1)-(2,6-Dimethoxy-4-pyrimidinyl)sulfanilamide | Sulfadimethoxine | Sulfadimethoxinum | Sulfadimethoxydiazine | Sulfadimetoxina | Sulphadimethoxine
|
ZZORFUFYDOWNEF-UHFFFAOYSA-N
|
DB06151
|
DB05436
|
Acetylcysteine
|
616-91-1
|
WYQ7N0BPYC
|
(2R)-2-acetylamino-3-sulfanylpropanoic acid | (R)-2-acetylamino-3-mercaptopropanoic acid | (R)-mercapturic acid | Acetilcisteina | Acetylcysteine | Acetylcysteinum | L-acetylcysteine | L-α-acetamido-β-mercaptopropionic acid | Mercapturic acid | N-acetyl-L-(+)-cysteine | N-acetyl-L-cysteine | N-acetylcysteine | NAC
|
PWKSKIMOESPYIA-BYPYZUCNSA-N
|
DB06152
| null |
Nylidrin
|
447-41-6
|
695DKH33EI
|
Bufenina | Buphenin | Buphenine | Bupheninum
|
PTGXAUBQBSGPKF-UHFFFAOYSA-N
|
DB06153
| null |
Pizotifen
|
15574-96-6
|
0BY8440V3N
|
Pizotifen | pizotifeno | Pizotyline
|
FIADGNVRKBPQEU-UHFFFAOYSA-N
|
DB06154
| null |
Pentaerythritol tetranitrate
|
78-11-5
|
10L39TRG1Z
|
Corpent | PENT | PENTA | Pentaerithrityl tetranitrate | pentaerithrityli tetranitras | Pentaerythritol tetranitrate | Penthrite | TEN | Tetranitrate de pentaerithrityle | Tetranitrato de pentaeritritilo
|
TZRXHJWUDPFEEY-UHFFFAOYSA-N
|
DB06155
| null |
Rimonabant
|
168273-06-1
|
RML78EN3XE
|
Rimonabant
|
JZCPYUJPEARBJL-UHFFFAOYSA-N
|
DB06156
| null |
Tesofensine
|
195875-84-4
|
BLH9UKX9V1
|
Tesofensine
|
VCVWXKKWDOJNIT-ZOMKSWQUSA-N
|
DB06157
| null |
Istaroxime
|
203737-93-3
|
W8I9H2TPPL
|
(E,Z)-Istaroxime | 3-((2-Aminoethoxy)imino)-5alpha-androstan-6,17-dione | Istaroxime
|
MPYLDWFDPHRTEG-IFVNMTGRSA-N
|
DB06159
| null |
Rubitecan
|
91421-42-0
|
H19C446XXB
|
1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE, 4-ETHYL-4-HYDROXY-10-NITRO-, (4S)- | 9-NC | 9-nitro-(20S)-camptothecin | 9-nitro-20-(S)-camptothecin | 9-nitro-20(S)-camptothecin | 9-nitrocamptothecin | 9NC | Rubitecán | Rubitécan | Rubitecan | Rubitecanum
|
VHXNKPBCCMUMSW-FQEVSTJZSA-N
|
DB06160
| null |
Garenoxacin
|
194804-75-6
|
V72H9867WB
|
Garenoxacin | Garénoxacine | Garenoxacino | Garenoxacinum
|
NJDRXTDGYFKORP-LLVKDONJSA-N
|
DB06161
| null |
Opebacan
|
206254-79-7
|
4X9EPQ6FMA
|
1-193-BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN (132-ALANINE) (HUMAN REDUCED) | 1-193-BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN (132-ALANINE) (HUMAN) | BACTERICIDAL PERMEABILITY-INCREASING PROTEIN OPEBACAN [MI] | Opebacan
| null |
DB06162
| null |
Lumiliximab
|
357613-86-6
|
8Z13S29R5A
|
Gomiliximab | IMMUNOGLOBULIN G1, ANTI-(HUMAN IMMUNOGLOBULIN E RECEPTOR TYPE II) (HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .KAPPA.-CHAIN, DIMER | IMMUNOGLOBULIN G1, ANTI-(HUMAN IMMUNOGLOBULIN E RECEPTOR TYPE II) (HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .KAPPA.-CHAIN, DIMER | Lumiliximab | PRIMATIZED ANTI-CD23
| null |
DB06163
| null |
Plevitrexed
|
153537-73-6
|
L9P2881C3H
|
Plevitrexed
|
IEJSCSAMMLUINT-NRFANRHFSA-N
|
DB06166
| null |
Fosdevirine
|
1018450-26-4
|
Z4I0C281BJ
|
Fosdevirine
|
CGBYTKOSZYQOPV-CCEZBSFNSA-N
|
DB06168
| null |
Canakinumab
|
914613-48-2
|
37CQ2C7X93
|
Canakinumab
| null |
DB06169
| null |
Indibulin
|
204205-90-3
|
80K4H2RB8P
|
Indibulin
|
SOLIIYNRSAWTSQ-UHFFFAOYSA-N
|
DB06171
| null |
Paclitaxel trevatide
|
1075214-55-9
|
8P77G99D3P
|
[a-N-(2'succinyl-paclitaxel)Thr]-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-[epsilon-N-(2'succinyl-paclitaxel)Lys]-Arg-Asn-Asn-Phe-[epsilon-N-(2'succinyl-paclitaxel)Lys]-Thr-Glu-Glu-Tyr | Paclitaxel trevatide
| null |
DB06174
| null |
Noscapine
|
128-62-1
|
8V32U4AOQU
|
(−)-narcotine | (−)-α-narcotine | alpha-Narcotine | Noscapina | Noscapine | Noscapinum
|
AKNNEGZIBPJZJG-MSOLQXFVSA-N
|
DB06175
| null |
TGAAC94
| null | null | null | null |
DB06176
| null |
Romidepsin
|
128517-07-7
|
CX3T89XQBK
|
Romidepsin | Romidepsina | Romidepsine | Romidepsinum
|
OHRURASPPZQGQM-GCCNXGTGSA-N
|
DB06177
| null |
Glufosfamide
|
132682-98-5
|
1W5N8SZD9A
|
Glufosfamide
|
PSVUJBVBCOISSP-SPFKKGSWSA-N
|
DB06178
| null |
Talotrexin
|
113857-87-7
|
A8E516A20K
|
Talotrexin
|
NYQPLPNEESYGNO-IBGZPJMESA-N
|
DB06179
| null |
Darinaparsin
|
69819-86-9
|
9XX54M675G
|
Darinaparsin
|
JGDXFQORBMPJGR-YUMQZZPRSA-N
|
DB06180
| null |
TG1024
| null | null |
Ad-IL2
| null |
DB06181
| null |
EMD-1201081
|
847484-35-9
|
8566421Q5R
|
Amplivax | IMOXINE
| null |
DB06182
| null |
Talabostat
|
149682-77-9
|
KZ1O2SH88Z
|
Talabostat
|
FKCMADOPPWWGNZ-YUMQZZPRSA-N
|
DB06184
| null |
AEG35156
| null | null | null | null |
DB06185
|
DB03743
|
Forodesine
|
209799-67-7
|
426X066ELK
|
(1S)-1,4-dideoxy-4-imino-(9-deazahypoxanthin-9-yl)-D-ribitol | 1,4-Dideoxy-4-aza-1-(S)-(9-deazahypoxanthin-9-yl)-D-ribitol | Forodesine | Immucillin H | Immucillin-H
|
IWKXDMQDITUYRK-KUBHLMPHSA-N
|
DB06186
| null |
Ipilimumab
|
477202-00-9
|
6T8C155666
|
Ipilimumab
| null |
DB06187
| null |
Valtorcitabine
|
380886-95-3
|
D5YQG6AQXP
|
Valtorcitabine
|
VFCYZPOEGWLYRM-QCZKYFFMSA-N
|
DB06188
| null |
Ispinesib
|
336113-53-2
|
BKT5F9C2NI
|
Ispinesib
|
QJZRFPJCWMNVAV-HHHXNRCGSA-N
|
DB06190
| null |
Solabegron
|
252920-94-8
|
55P6YH9O6N
|
Solabegron
|
LLDXOPKUNJTIRF-QFIPXVFZSA-N
|
DB06191
| null |
Zosuquidar
|
167354-41-8
|
AB5K82X98Y
|
Zosuquidar
|
IHOVFYSQUDPMCN-DBEBIPAYSA-N
|
DB06192
| null |
Nimotuzumab
|
780758-10-3
|
6NS400BXKH
|
Nimotuzumab
| null |
DB06193
| null |
Pixantrone
|
144510-96-3
|
F5SXN2KNMR
|
6,9-bis((2-aminoethyl)amino)benzo(g)isoquinoline-5,10-dione | Pixantrona | Pixantrone
|
PEZPMAYDXJQYRV-UHFFFAOYSA-N
|
DB06194
| null |
Elocalcitol
|
199798-84-0
|
2WDS5F2V6Q
|
Elocalcitol
|
LRLWXBHFPGSUOX-GJQYOBCGSA-N
|
DB06195
| null |
Seliciclib
|
186692-46-6
|
0ES1C2KQ94
|
2-(R)-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine | R-roscovitine | Seliciclib
|
BTIHMVBBUGXLCJ-OAHLLOKOSA-N
|
DB06196
| null |
Icatibant
|
130308-48-4
|
7PG89G35Q7
|
Icatibant
| null |
DB06197
| null |
Bimosiamose
|
187269-40-5
|
97B5KCW80W
|
Bimosiamose
|
RYWCQJDEHXJHRI-XJMXIVSISA-N
|
DB06198
| null |
Alovudine
|
25526-93-6
|
PG53R0DWDQ
|
Alovudine
|
UXCAQJAQSWSNPQ-XLPZGREQSA-N
|
DB06199
| null |
Atrasentan
|
173937-91-2
|
V6D7VK2215
|
Atrasentan
|
MOTJMGVDPWRKOC-QPVYNBJUSA-N
|
DB06200
| null |
Tedisamil
|
90961-53-8
|
A5VAY2U3R8
|
Tedisamil
|
CTIRHWCPXYGDGF-UHFFFAOYSA-N
|
DB06201
| null |
Rufinamide
|
106308-44-5
|
WFW942PR79
|
Rufinamida | Rufinamide | Xilep
|
POGQSBRIGCQNEG-UHFFFAOYSA-N
|
DB06202
| null |
Lasofoxifene
|
180916-16-9
|
337G83N988
|
(-)-cis-5,6,7,8-Tetrahydro-6-phenyl-5-(p-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-naphthol | Lasofoxifene
|
GXESHMAMLJKROZ-IAPPQJPRSA-N
|
DB06203
| null |
Alogliptin
|
850649-61-5
|
JHC049LO86
|
Alogliptin | Alogliptina | Alogliptine | Alogliptinum
|
ZSBOMTDTBDDKMP-OAHLLOKOSA-N
|
DB06204
| null |
Tapentadol
|
175591-23-8
|
H8A007M585
|
3-[(1R,2R)-3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol | PHENOL, 3-((1R,2R)-3-(DIMETHYLAMINO)-1-ETHYL-2-METHYLPROPYL)- | Tapentadol
|
KWTWDQCKEHXFFR-SMDDNHRTSA-N
|
DB06205
| null |
Hyaluronidase (human recombinant)
|
757971-58-7
|
743QUY4VD8
|
Hyaluronidase (human recombinant) | Hyaluronidase human recombinant | Hyaluronidase recombinant human | Hyaluronidase, human | Recombinant human hyaluronidase | Vorhyaluronidase alfa
| null |
DB06206
| null |
Sugammadex
|
343306-71-8
|
361LPM2T56
|
Sugammadex
|
WHRODDIHRRDWEW-VTHZAVIASA-N
|
DB06207
| null |
Silodosin
|
160970-54-7
|
CUZ39LUY82
|
Silodosin | Silodosina
|
PNCPYILNMDWPEY-QGZVFWFLSA-N
|
DB06208
| null |
PB127
| null |
QWA911J5C7
| null | null |
DB06209
| null |
Prasugrel
|
150322-43-3
|
34K66TBT99
|
Prasugrel
|
DTGLZDAWLRGWQN-UHFFFAOYSA-N
|
DB06210
| null |
Eltrombopag
|
496775-61-2
|
S56D65XJ9G
|
Eltrombopag | Eltrombopagum
|
XDXWLKQMMKQXPV-QYQHSDTDSA-N
|
DB06211
| null |
Doripenem
|
148016-81-3
|
BHV525JOBH
|
Doripenem
|
AVAACINZEOAHHE-VFZPANTDSA-N
|
DB06212
| null |
Tolvaptan
|
150683-30-0
|
1E2497LPNY
| null |
GYHCTFXIZSNGJT-XMMPIXPASA-N
|
DB06213
| null |
Regadenoson
|
313348-27-5
|
7AXV542LZ4
|
Regadenoson | Regadenoson anhydrous
|
LZPZPHGJDAGEJZ-AKAIJSEGSA-N
|
DB06215
| null |
Ferumoxytol
|
722492-56-0
|
CLH5FT6412
|
Ferumoxytol | Ferumoxytol non-stoichiometric magnetite
|
WTFXARWRTYJXII-UHFFFAOYSA-N
|
DB06216
| null |
Asenapine
|
65576-45-6
|
JKZ19V908O
|
Asenapina | Asenapine
|
VSWBSWWIRNCQIJ-UHFFFAOYSA-N
|
DB06217
| null |
Vernakalant
|
794466-70-9
|
9G468C8B13
|
(3R)-1-((1R,2R)-2-(2-(3,4-dimethoxyphenyl)ethoxy)cyclohexyl)pyrrolidin-3-ol | Vernakalant
|
VBHQKCBVWWUUKN-KZNAEPCWSA-N
|
DB06218
| null |
Lacosamide
|
175481-36-4
|
563KS2PQY5
|
(+)-(2R)-2-(ACETYLAMINO)-N-BENZYL-3-METHOXYPROPANAMIDE | (2R)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide | (R)-2-acetamido-N-benzyl-3- methoxypropionamide | (R)-LACOSAMIDE 1 | Erlosamide | Harkoseride | Lacosamida | Lacosamide | Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (2R)-
|
VPPJLAIAVCUEMN-GFCCVEGCSA-N
|
DB06219
| null |
Dalbavancin
|
171500-79-1
|
808UI9MS5K
|
Dalbavancin | Dalbavancina
| null |
DB06224
| null |
Alicaforsen
|
185229-68-9
|
J8435V445B
|
Alicaforsen
| null |
DB06225
| null |
HMR4011
| null | null | null | null |
DB06226
| null |
Nelipepimut-S
|
160212-35-1
|
7M0A29CD8B
|
HER-2/NEU PEPTIDE (369-377) | HER2 369-377 | Human receptor tyrosine-protein kinase erbB-2 (proto-oncogene Neu, tyrosine kinase-type cell surface receptor HER2, CD340)-(347-355)-peptide | Nelipepimut S | Nelipepimut-S | NEUVAX
| null |
DB06228
|
DB08477
|
Rivaroxaban
|
366789-02-8
|
9NDF7JZ4M3
|
Rivaroxaban
|
KGFYHTZWPPHNLQ-AWEZNQCLSA-N
|
DB06229
| null |
Ocaperidone
|
129029-23-8
|
26HUS7139V
|
Ocaperidona | Ocaperidone | Ocaperidonum
|
ZZQNEJILGNNOEP-UHFFFAOYSA-N
|
DB06230
| null |
Nalmefene
|
55096-26-9
|
TOV02TDP9I
|
17-(Cyclopropylmethyl)-4,5α-epoxy-6-methylenemorphinan-3,14-diol | MORPHINAN-3,14-DIOL, 17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-6-METHYLENE-, (5.ALPHA.)- | Nalmefene | Nalmefeno
|
WJBLNOPPDWQMCH-MBPVOVBZSA-N
|
DB06231
| null |
Caldaret
|
133804-44-1
|
9L3Y3IJ2HI
|
Caldaret
|
DCDFLGVJWQIRGH-UHFFFAOYSA-N
|
DB06233
| null |
Ridaforolimus
|
572924-54-0
|
48Z35KB15K
|
Deforolimus | Ridaforolimus
|
BUROJSBIWGDYCN-GAUTUEMISA-N
|
DB06234
| null |
Maribavir
|
176161-24-3
|
PTB4X93HE1
|
Maribavir
|
KJFBVJALEQWJBS-XUXIUFHCSA-N
|
DB06235
|
DB13081
|
Vadimezan
|
117570-53-3
|
0829J8133H
|
(5,6-dimethyl-9-oxoxanthen-4-yl)acetic acid | 5,6-Dimethyl-9-oxo-9H-xanthene-4-acetic acid | 5,6-Dimethylxanthenone-4-acetic acid | 5,6-Dimethylxanthenoneacetic acid | 5,6-MeXAA | Dimethyloxoxanthene acetic acid | DMXAA | Vadimézan | Vadimezan | Vadimezanum
|
XGOYIMQSIKSOBS-UHFFFAOYSA-N
|
DB06236
| null |
Elvucitabine
|
181785-84-2
|
M09BUF90C0
|
B-L-Fd4C | Elvucitabine
|
HSBKFSPNDWWPSL-VDTYLAMSSA-N
|
DB06237
| null |
Avanafil
|
330784-47-9
|
DR5S136IVO
|
(S)-4-(3-Chloro-4-methoxybenzylamino)-2-(2-hydroxymethylpyrrolidin-1-yl)-N-pyrimidin-2-ylmethyl-5-pyrimidinecarboxamide | Avanafil | Avanafilo
|
WEAJZXNPAWBCOA-INIZCTEOSA-N
|
DB06239
| null |
Tipapkinogene sovacivec
|
1052105-48-2
|
P34L5Y2SR5
|
DNA (synthetic vaccinia virus strain MVA human papillomavirus-targeted) | MVA-HPV-IL2 vaccine | Tipapkinogene sovacivec
| null |
DB06240
| null |
Tariquidar
|
206873-63-4
|
J58862DTVD
|
Tariquidar
|
LGGHDPFKSSRQNS-UHFFFAOYSA-N
|
DB06241
| null |
Clenoliximab
| null | null |
Clenoliximab
| null |
DB06243
| null |
Eflornithine
|
70052-12-9
|
ZQN1G5V6SR
|
(RS)-2,5-diamino-2-(difluoromethyl)pentanoic acid | 2-(difluoromethyl)ornithine | alpha-difluoromethylornithine | DFMO | Eflornithine | α-difluoromethylornithine
|
VLCYCQAOQCDTCN-UHFFFAOYSA-N
|
DB06244
| null |
Trafermin
|
131094-16-1
|
333OX80X87
|
Recombinant human basic fibroblast growth factor | rhbFGF | Trafermin
| null |
DB06245
| null |
Lanoteplase
|
171870-23-8
|
5U26HTF8RV
|
Lanoteplase
| null |
DB06246
| null |
Exisulind
|
59973-80-7
|
K619IIG2R9
|
5-Fluoro-2-methyl-1-((Z)-p-(methylsulfonyl)benzylidene)indene-3-acetic acid | cis-5-Fluoro-2-methyl-1-(p-methylsulfonylbenzylidenyl)indene-3-acetic acid | Exisulind | Sulindac sulfone
|
MVGSNCBCUWPVDA-MFOYZWKCSA-N
|
DB06247
| null |
CX516
|
154235-83-3
|
Z5QU38B4V9
| null |
ANDGGVOPIJEHOF-UHFFFAOYSA-N
|
DB06248
| null |
Amelubant
|
346735-24-8
|
E0018IF0K4
|
Amelubant | Carbamic acid, N-[[4-[[3-[[4-[1-(4-hydroxyphenyl)-1-methylethyl]phenoxy]methyl]phenyl]methoxy]phenyl]iminomethyl]-, ethyl ester
|
SBVYURPQULDJTI-UHFFFAOYSA-N
|
DB06249
| null |
Arzoxifene
|
182133-25-1
|
E569WG6E60
|
Arzoxifene
|
MCGDSOGUHLTADD-UHFFFAOYSA-N
|
DB06250
| null |
Fluasterone
|
112859-71-9
|
R7M5UGD04G
| null |
VHZXNQKVFDBFIK-NBBHSKLNSA-N
|
DB06251
| null |
Dersalazine
|
188913-58-8
|
WS1IH75AJT
|
Dersalazine
|
AYEAMZDTWLXZIJ-RKOUKRECSA-N
|
DB06252
| null |
R112
|
575474-82-7
|
Y7W5AL9KHB
|
3-((5-FLUORO-2-(3-HYDROXYANILINO)PYRIMIDIN-4-YL)AMINO)PHENOL | 3,3'-((5-FLUORO-2,4-PYRIMIDINEDIYL)DIIMINO)BIS(PHENOL) | PHENOL, 3,3'-((5-FLUORO-2,4-PYRIMIDINEDIYL)DIIMINO)BIS-
|
TVKGTSHBQZEFEE-UHFFFAOYSA-N
|
DB06253
| null |
Thioctic acid tromethamine
|
137314-40-0
|
HK7B1AJA3Q
|
(R)-5-(1,2-dithiolaln-3-yl)-pentanoic acid tromethamine | Thioctic acid tromethamine
|
CCTREOMTIFSZAU-OGFXRTJISA-N
|
DB06255
| null |
Incadronic acid
|
124351-85-5
|
G5C4M8847E
|
Cimadronate | Incadronate | Incadronic acid
|
LWRDQHOZTAOILO-UHFFFAOYSA-N
|
DB06256
| null |
rPSGL-Ig
| null | null |
Recombinant P-selectin glycoprotein ligand-immunoglobulin Ig | Recombinant soluble PSGL-1 Fc chimera | rPSGL-1-Ig | rPSGL-Ig | YSPSL
| null |
DB06257
| null |
HE-2200
|
2697-85-0
|
Q0CZ537GC8
|
beta-Aet
|
OEVZKEVBDIDVOI-YSZCXEEOSA-N
|
DB06258
| null |
Bimoclomol
|
130493-03-7
|
9IYF14814M
|
Bimoclomol
|
NMOVJBAGBXIKCG-VKAVYKQESA-N
|
DB06260
| null |
Aviptadil
|
40077-57-4
|
A67JUW790C
|
Aviptadil | Porcine vasoactive intestinal octacosapeptide | Vasoactive intestinal octacosapeptide (pig) | Vasoactive intestinal octacosapeptide (swine)
|
OIDGWOIMPADMGM-GXSWRUKYSA-N
|
DB06261
| null |
Hexaminolevulinate
|
140898-97-1
|
G7H20TKI67
|
4-Hexyloxycarbonyl-2-oxobutylammoniumchloride | Hexaminolevulinato | Hexyl 5-amino-4-oxopentanoate hydrochloride | Hexyl(5-amino-4-oxopentanoat)-hydrochlorid | Pentanoic acid, 5-amino-4-oxo-, hexyl ester, hydrochloride
|
RYQOILLJDKPETL-UHFFFAOYSA-N
|
DB06262
| null |
Droxidopa
|
23651-95-8
|
J7A92W69L7
|
DOPS | Droxidopa | L-Dihydroxyphenylserine | L-DOPS | L-threo-dihydroxyphenylserine
|
QXWYKJLNLSIPIN-JGVFFNPUSA-N
|
DB06263
| null |
Amrubicin
|
110267-81-7
|
93N13LB4Z2
|
Amrubicin
|
VJZITPJGSQKZMX-XDPRQOKASA-N
|
DB06264
| null |
Tolperisone
|
728-88-1
|
F5EOM0LD8E
|
Tolperisone
|
FSKFPVLPFLJRQB-UHFFFAOYSA-N
|
DB06266
|
DB03762
|
Lonidamine
|
50264-69-2
|
U78804BIDR
|
1-(2,4-dichlorbenzyl)-indazole-3-carboxylic acid | DICA | diclondazolic acid | Doridamina | Lonidamin | lonidamina | Lonidamine | lonidaminum
|
WDRYRZXSPDWGEB-UHFFFAOYSA-N
|
DB06267
| null |
Udenafil
|
268203-93-6
|
L5IB4XLY36
|
Udenafil
|
IYFNEFQTYQPVOC-UHFFFAOYSA-N
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.